T1	Participants 32 61	patients with HIV-1 infection
T2	Participants 227 352	12 patients with human immunodeficiency virus type-1 (HIV-1) infection 3-12 months after initiation of antiretroviral therapy
T3	Participants 801 840	immunoactivation during HIV-1 infection
